PEG-20k
The major mechanism of action of PEG-20k IV solution in treating severe hypovolemic shock is to increase tissue perfusion to facilitate rapid transfer of oxygen into oxygen starved tissues and organs. Research suggest that PEG-20k’s biological mechanism is shared by other clinical events associated with traumatic shock including cardiac illness, critical illness, sepsis and vascular disease.
Potential Treatment For:
Hemorrhagic Shock
1.9 M
Annual Lives Lost Worldwide
Traumatic Brain Injury
2.8 M
Injuries Annually US
Potential Treatment For:
Heart Attacks
805 K
Annually US
Congestive Heart Failure
875 K
Hospitalizations Annually US
ICU/ Critical Illness
Potential Treatment For:
Sepsis
1.7 M
Annually US
Acute Respiratory Distress Syndrome
190 K
Annually US
Vascular Disease
Potential Treatment For:
Peripheral Vascular Disease
8.5 M
Cases per year - US
Sickle Cell Crisis
1.2 M
Cases per year - US